SecProbe.io

Stored correspondence activity detail
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

Correspondence Activity Detail

Estrella Immunopharma, Inc. (ESLA, ESLAW) (CIK 0001844417) (ESLA)
Activity window: Oct. 25, 2025 to Oct. 24, 2026

Back View Correspondence Compare Probe Scores Download Probe Score CSV

Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.

Probe Score Breakdown

Current total
1.5 / 10
Correspondence-letter component
1.0
AI sentiment component
0.5
Keyword-match component
0.0
Signal-match component
0.0
Notable 8-K modifier
0.0

The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Jan. 22, 2026. These dates describe different events.

Correspondence Filings
1
Keyword Matches
0
Latest Activity
Jan. 22, 2026
Related 8-Ks
0

Matched Signals

No stored keyword or signal matches were recorded for this activity window.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Jan. 22, 2026 CORRESP Neutral/Informational Moderate Estrella Immunopharma, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1, originally filed on December… Read Filing EDGAR
Dec. 29, 2025 UPLOAD Neutral/Informational Low The SEC has communicated to Estrella Immunopharma, Inc. that it will not review the company's registration statement filed on December 22, 2025. The letter emphasizes the company'… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in this activity window.